Last updated on April 17, 2014 at 11:32 EDT

Metabolix Executives to Present at Leading Industry Conferences

June 10, 2013

CAMBRIDGE, Mass., June 10, 2013 /PRNewswire/ – Metabolix, Inc. (NASDAQ: MBLX), an innovation-driven bioscience company focused on delivering sustainable solutions for plastics, chemicals and energy, today announced that its executives will be presenting at two leading industry conferences in June. Metabolix President and Chief Executive Officer Richard P. Eno will discuss trends in the biopolymers industry at Smithers Rapra’s Biopolymers Symposium 2013 on June 11, and he will moderate a panel at the Biotechnology Industry Organization’s (BIO) 10(th) Annual World Congress on Industrial Biotechnology on June 19. In addition, Max Senechal, Metabolix’s vice president of biobased chemicals, will discuss commercialization strategies for renewable chemicals at BIO World Congress on June 17.

(Logo: http://photos.prnewswire.com/prnh/20130607/NE28327LOGO-b)

At the Biopolymers Symposium, Mr. Eno will participate in a panel discussion with executives from NatureWorks and Virent. The session will focus on the future of biopolymers, and Mr. Eno will address Metabolix’s experience working with customers to achieve commercial success.

At the BIO World Congress on Industrial Biotechnology, Mr. Senechal will participate in the “Renewable Chemicals through Strain Engineering and Process Optimization” panel discussion. Executives and researchers from Green Biologics, zuChem, PRAJ-Matrix and the University of Illinois will also be part of the session. Separately, Mr. Eno will be moderating the “Biomanufacturing at Commercial Scale” panel discussion on commercializing renewable chemicals with executives from Genomatica, Myriant, Clariant and Ajinomoto.

    Smithers Rapra's Biopolymers Symposium 2013

    What:                           "The Future of Biopolymers"
                                    panel discussion

    Who:                            Richard Eno, president and CEO,

    When:                           Tuesday, June 11, 2013 from
                                    8:40-9:40 a.m.

    Where:                         The Field Museum

                                   1400 S Lake Shore Drive

                                   Chicago, IL, 60605

    BIO's 10th Annual World Congress on Industrial Biotechnology

    What:                           "Renewable Chemicals through Strain
                                    Engineering and Process Optimization" and
                                    "Biomanufacturing at Commercial Scale"
                                    panel discussions

    Who:                            Max Senechal, vice president of biobased
                                    chemicals, and Richard Eno, president and
                                    CEO, Metabolix

    When:                           Monday, June 17 from 8:30-10 a.m.
                                    (Senechal) and Wednesday, June 19 from
                                    8-10 a.m. (Eno)

    Where:                         Palais des congres de Montreal

                                   159 Saint-Antoine West, 9th floor

                                   Montreal (Quebec) H2Z 1H2, Canada

About Metabolix

Metabolix, Inc. is an innovation-driven bioscience company delivering sustainable solutions to the plastics, chemicals and energy industries. Metabolix is developing and commercializing a family of high-performance biopolymers targeted to the markets for film and bag applications, performance additives and functional biodegradation. Metabolix’s biobased chemicals platform utilizes its novel “FAST” recovery process to enable the production of cost-effective, alternative replacements for petroleum-based industrial chemicals. Metabolix is also developing a platform for co-producing plastics, chemicals and energy from crops. Metabolix has established an industry-leading intellectual property portfolio that, together with its knowledge of advanced industrial practice, provides a foundation for industry collaborations.

For more information, please visit www.metabolix.com. (MBLX-G)

SOURCE Metabolix, Inc.

Source: PR Newswire